MDM2 and prostate carcinoma: Same findings were also shown in human prostate carcinoma LNCaP cells that EGCG induced apoptosis via stabilization of p53, downregulation of MDM2 protein, and negative regulation of NF-κB activity, thereby decreasing the expression of Bcl-2 (Hastak et al., 2003).